Tripartite competition on COPD markets.

Published: 2003-12-15 07:00:00
Updated: 2003-12-15 07:00:00
The business interests in the chronic obstructive pulmonary disease (COPD) therapy is surging up slowly to the market and very competitive by 3 big foreign drug corporations, AstraZeneca, GSK and Boehringer/Pfizer.

COPD is a chronic obstructive respiratory tract disorder with symptoms of cough...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.